Literature DB >> 4628732

Kinetics of aurothiomalate in serum and synovial fluid.

R C Gerber, H E Paulus, R Bluestone, M Lederer.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 4628732     DOI: 10.1002/art.1780150609

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  13 in total

1.  Selective concentration and localization of gold in macrophages of synovial and other tissues during and after chrysotherapy in rheumatoid patients.

Authors:  B Vernon-Roberts; J L Doré; J D Jessop; W J Henderson
Journal:  Ann Rheum Dis       Date:  1976-12       Impact factor: 19.103

2.  Distribution of gold among plasma fractions in rheumatoid patients undergoing chrysotherapy compared with its distribution in plasma incubated with aurothiomalate in vitro.

Authors:  C J Danpure; D A Fyfe; J M Gumpel
Journal:  Ann Rheum Dis       Date:  1979-08       Impact factor: 19.103

3.  Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.

Authors:  M Farr; A Brodrick; P A Bacon
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

Review 4.  Clinical pharmacokinetics of oral and injectable gold compounds.

Authors:  K L Blocka; H E Paulus; D E Furst
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

Review 5.  Monitoring gold plasma levels in rheumatoid arthritis.

Authors:  A Lorber
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

6.  Simultaneous pharmacokinetics of indomethacin in serum and synovial fluid.

Authors:  H W Emori; G D Champion; R Bluestone; H E Paulus
Journal:  Ann Rheum Dis       Date:  1973-09       Impact factor: 19.103

Review 7.  Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics.

Authors:  W J Wallis; P A Simkin
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

Review 8.  Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.

Authors:  M Chaffman; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

9.  Comparative pharmacokinetics of triethylphosphine gold (auranofin) and gold sodium thiomalate (GST).

Authors:  D E Furst; S H Dromgoole
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

Review 10.  Clinical pharmacokinetics of drugs used in juvenile arthritis.

Authors:  K J Skeith; F Jamali
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.